• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无驱动基因的肺腺癌通过不同的遗传、表观遗传和小生境构建进化途径汇聚到共同的适应性策略。

Lung adenocarcinomas without driver genes converge to common adaptive strategies through diverse genetic, epigenetic, and niche construction evolutionary pathways.

机构信息

Department of Cancer Biology and Evolution, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL, 33612, USA.

Department of Bioinformatics, Moffitt Cancer Center, Tampa, USA.

出版信息

Med Oncol. 2024 May 5;41(6):135. doi: 10.1007/s12032-024-02344-2.

DOI:10.1007/s12032-024-02344-2
PMID:38704802
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11070398/
Abstract

Somatic evolution selects cancer cell phenotypes that maximize survival and proliferation in dynamic environments. Although cancer cells are molecularly heterogeneous, we hypothesized convergent adaptive strategies to common host selection forces can be inferred from patterns of epigenetic and genetic evolutionary selection in similar tumors. We systematically investigated gene mutations and expression changes in lung adenocarcinomas with no common driver genes (n = 313). Although 13,461 genes were mutated in at least one sample, only 376 non-synonymous mutations evidenced positive evolutionary selection with conservation of 224 genes, while 1736 and 2430 genes exhibited ≥ two-fold increased and ≥ 50% decreased expression, respectively. Mutations under positive selection are more frequent in genes with significantly altered expression suggesting they often "hardwire" pre-existing epigenetically driven adaptations. Conserved genes averaged 16-fold higher expression in normal lung tissue compared to those with selected mutations demonstrating pathways necessary for both normal cell function and optimal cancer cell fitness. The convergent LUAD phenotype exhibits loss of differentiated functions and cell-cell interactions governing tissue organization. Conservation with increased expression is found in genes associated with cell cycle, DNA repair, p53 pathway, epigenetic modifiers, and glucose metabolism. No canonical driver gene pathways exhibit strong positive selection, but extensive down-regulation of membrane ion channels suggests decreased transmembrane potential may generate persistent proliferative signals. NCD LUADs perform niche construction generating a stiff, immunosuppressive microenvironment through selection of specific collagens and proteases. NCD LUADs evolve to a convergent phenotype through a network of interconnected genetic, epigenetic, and ecological pathways.

摘要

体细胞进化选择了最大限度地提高在动态环境中生存和增殖能力的癌细胞表型。尽管癌细胞在分子上是异质的,但我们假设,从类似肿瘤中观察到的表观遗传和遗传进化选择模式中,可以推断出针对常见宿主选择压力的趋同适应策略。我们系统地研究了无共同驱动基因的肺腺癌(n = 313)中的基因突变和表达变化。尽管至少有一个样本中存在 13461 个基因突变,但只有 376 个非同义突变具有正向进化选择的证据,其中 224 个基因得到了保守,而 1736 个和 2430 个基因分别表现出两倍以上的增加和 50%以上的减少表达。正向选择下的突变在表达发生显著改变的基因中更为常见,这表明它们经常“硬连线”预先存在的表观遗传驱动适应性。与具有选择突变的基因相比,保守基因在正常肺组织中的表达平均高出 16 倍,这表明它们是正常细胞功能和最佳癌细胞适应性所必需的途径。趋同的 LUAD 表型表现出分化功能丧失和控制组织组织的细胞-细胞相互作用。在与细胞周期、DNA 修复、p53 途径、表观遗传修饰剂和葡萄糖代谢相关的基因中发现了保守且表达增加的现象。没有经典的驱动基因途径表现出强烈的正向选择,但膜离子通道的广泛下调表明,跨膜电位的降低可能产生持续的增殖信号。NCD LUAD 通过选择特定的胶原蛋白和蛋白酶,通过一系列相互关联的遗传、表观遗传和生态途径,来构建生态位,从而产生坚硬、免疫抑制的微环境。NCD LUAD 通过相互关联的遗传、表观遗传和生态途径,进化为趋同表型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1c0/11070398/6b0b1b51654b/12032_2024_2344_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1c0/11070398/9f821cb46b22/12032_2024_2344_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1c0/11070398/a4ae7ca3aab4/12032_2024_2344_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1c0/11070398/0633061057d5/12032_2024_2344_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1c0/11070398/c1c18fe234c8/12032_2024_2344_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1c0/11070398/6b0b1b51654b/12032_2024_2344_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1c0/11070398/9f821cb46b22/12032_2024_2344_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1c0/11070398/a4ae7ca3aab4/12032_2024_2344_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1c0/11070398/0633061057d5/12032_2024_2344_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1c0/11070398/c1c18fe234c8/12032_2024_2344_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1c0/11070398/6b0b1b51654b/12032_2024_2344_Fig5_HTML.jpg

相似文献

1
Lung adenocarcinomas without driver genes converge to common adaptive strategies through diverse genetic, epigenetic, and niche construction evolutionary pathways.无驱动基因的肺腺癌通过不同的遗传、表观遗传和小生境构建进化途径汇聚到共同的适应性策略。
Med Oncol. 2024 May 5;41(6):135. doi: 10.1007/s12032-024-02344-2.
2
Evolutionary Analysis of TCGA Data Using Over- and Under- Mutated Genes Identify Key Molecular Pathways and Cellular Functions in Lung Cancer Subtypes.使用过突变和低突变基因对TCGA数据进行进化分析,以识别肺癌亚型中的关键分子途径和细胞功能。
Cancers (Basel). 2022 Dec 20;15(1):18. doi: 10.3390/cancers15010018.
3
Intratumoral immunoglobulin isotypes predict survival in lung adenocarcinoma subtypes.肿瘤内免疫球蛋白同种型可预测肺腺癌亚型的生存。
J Immunother Cancer. 2019 Oct 29;7(1):279. doi: 10.1186/s40425-019-0747-1.
4
Genomic Landscape and Immune Microenvironment Features of Preinvasive and Early Invasive Lung Adenocarcinoma.肺浸润前和早期浸润性腺癌的基因组景观和免疫微环境特征。
J Thorac Oncol. 2019 Nov;14(11):1912-1923. doi: 10.1016/j.jtho.2019.07.031. Epub 2019 Aug 22.
5
Single-cell RNA sequencing reveals heterogeneous tumor and immune cell populations in early-stage lung adenocarcinomas harboring EGFR mutations.单细胞 RNA 测序揭示了携带 EGFR 突变的早期肺腺癌中肿瘤和免疫细胞群体的异质性。
Oncogene. 2021 Jan;40(2):355-368. doi: 10.1038/s41388-020-01528-0. Epub 2020 Nov 3.
6
Lung adenocarcinoma patients with KEAP1 mutation harboring low immune cell infiltration and low activity of immune environment.肺腺癌患者带有 KEAP1 突变,其免疫细胞浸润低,免疫环境活性低。
Thorac Cancer. 2021 Sep;12(18):2458-2467. doi: 10.1111/1759-7714.14089. Epub 2021 Jul 30.
7
A risk model developed based on tumor microenvironment predicts overall survival and associates with tumor immunity of patients with lung adenocarcinoma.基于肿瘤微环境开发的风险模型可预测肺腺癌患者的总生存期,并与肿瘤免疫相关。
Oncogene. 2021 Jul;40(26):4413-4424. doi: 10.1038/s41388-021-01853-y. Epub 2021 Jun 9.
8
Common cancer-driver mutations and their association with abnormally methylated genes in lung adenocarcinoma from never-smokers.非吸烟肺腺癌中常见的癌症驱动突变及其与异常甲基化基因的相关性。
Lung Cancer. 2018 Sep;123:99-106. doi: 10.1016/j.lungcan.2018.07.011. Epub 2018 Jul 11.
9
Comparative profiling of single-cell transcriptome reveals heterogeneity of tumor microenvironment between solid and acinar lung adenocarcinoma.单细胞转录组比较分析揭示了实体型和腺泡型肺腺癌肿瘤微环境的异质性。
J Transl Med. 2022 Sep 23;20(1):423. doi: 10.1186/s12967-022-03620-3.
10
System analysis of in LUAD and LUSC: The expression, prognosis, gene regulation network, and regulation targets.肺腺癌(LUAD)和肺鳞癌(LUSC)中 的系统分析:表达、预后、基因调控网络和调控靶点。
Int J Biol Markers. 2022 Jun;37(2):158-169. doi: 10.1177/03936155221084056. Epub 2022 Mar 7.

引用本文的文献

1
Genetic overlap between sarcoidosis and lung cancer: a combined in silico and in vitro approach.结节病与肺癌之间的遗传重叠:一种计算机模拟与体外实验相结合的方法。
Hereditas. 2025 Aug 12;162(1):155. doi: 10.1186/s41065-025-00503-7.
2
Parallel and convergent dynamics in the evolution of primary breast and lung adenocarcinomas.原发性乳腺癌和肺癌进化中的平行与趋同动态
Commun Biol. 2025 May 21;8(1):775. doi: 10.1038/s42003-025-08123-7.

本文引用的文献

1
Evolutionary Analysis of TCGA Data Using Over- and Under- Mutated Genes Identify Key Molecular Pathways and Cellular Functions in Lung Cancer Subtypes.使用过突变和低突变基因对TCGA数据进行进化分析,以识别肺癌亚型中的关键分子途径和细胞功能。
Cancers (Basel). 2022 Dec 20;15(1):18. doi: 10.3390/cancers15010018.
2
The antigen CD300e drives T cell inflammation in adipose tissue and elicits an antibody response predictive of the insulin sensitivity recovery in obese patients.抗原CD300e驱动脂肪组织中的T细胞炎症,并引发一种可预测肥胖患者胰岛素敏感性恢复的抗体反应。
J Inflamm (Lond). 2022 Nov 22;19(1):21. doi: 10.1186/s12950-022-00318-7.
3
High expression COL10A1 promotes breast cancer progression and predicts poor prognosis.
高表达的COL10A1促进乳腺癌进展并预示不良预后。
Heliyon. 2022 Oct 17;8(10):e11083. doi: 10.1016/j.heliyon.2022.e11083. eCollection 2022 Oct.
4
COL10A1 allows stratification of invasiveness of colon cancer and associates to extracellular matrix and immune cell enrichment in the tumor parenchyma.COL10A1可对结肠癌的侵袭性进行分层,并与肿瘤实质中的细胞外基质和免疫细胞富集相关联。
Front Oncol. 2022 Oct 4;12:1007514. doi: 10.3389/fonc.2022.1007514. eCollection 2022.
5
COL11A1 serves as a biomarker for poor prognosis and correlates with immune infiltration in breast cancer.COL11A1作为乳腺癌预后不良的生物标志物,与免疫浸润相关。
Front Genet. 2022 Sep 9;13:935860. doi: 10.3389/fgene.2022.935860. eCollection 2022.
6
Evolutionary selection identifies critical immune-relevant genes in lung cancer subtypes.进化选择确定了肺癌亚型中与免疫相关的关键基因。
Front Genet. 2022 Aug 24;13:921447. doi: 10.3389/fgene.2022.921447. eCollection 2022.
7
Suppression of VEGFD expression by S-nitrosylation promotes the development of lung adenocarcinoma.S-亚硝基化抑制 VEGFD 表达促进肺腺癌的发展。
J Exp Clin Cancer Res. 2022 Aug 8;41(1):239. doi: 10.1186/s13046-022-02453-8.
8
EphA10 drives tumor progression and immune evasion by regulating the MAPK/ERK cascade in lung adenocarcinoma.EphA10 通过调节肺腺癌中的 MAPK/ERK 级联反应驱动肿瘤进展和免疫逃逸。
Int Immunopharmacol. 2022 Sep;110:109031. doi: 10.1016/j.intimp.2022.109031. Epub 2022 Jul 12.
9
The metastatic spread of breast cancer accelerates during sleep.乳腺癌的转移在睡眠期间加速。
Nature. 2022 Jul;607(7917):156-162. doi: 10.1038/s41586-022-04875-y. Epub 2022 Jun 22.
10
Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in ER (+) and/or PR (+) and HER2 (-) Breast Cancer.用于雌激素受体(ER)阳性和/或孕激素受体(PR)阳性及人表皮生长因子受体2(HER2)阴性乳腺癌生存风险分层和预后评估的新型免疫相关基因特征
Front Pharmacol. 2022 Jun 2;13:820437. doi: 10.3389/fphar.2022.820437. eCollection 2022.